Sugar-sweetened drinks raise risk of diabetes, metabolic syndrome

November 02, 2017

WASHINGTON--Regularly drinking sugar-sweetened beverages such as soda and juice contributes to the development of diabetes, high blood pressure and other endemic health problems, according to a review of epidemiological studies published in the Journal of the Endocrine Society.

The analysis also found a link between sugar-sweetened beverage consumption and the metabolic syndrome--a cluster of risk factors that raise the chances of developing heart disease, stroke and diabetes, according to the Hormone Health Network. The risk factors include abdominal obesity, high levels of fats in the blood known as triglycerides, elevated blood pressure, high-fasting blood sugar and reduced high-density lipoprotein (HDL), or good, cholesterol levels.

The World Health Organization estimates that cardiometabolic conditions such as the metabolic syndrome and diabetes result in 19 million deaths a year.

"Sugar-sweetened beverage consumption is steadily rising among all age groups worldwide," said the review's senior author, M. Faadiel Essop, Ph.D., of Stellenbosch University in Stellenbosch, South Africa. "Our analysis revealed that most epidemiological studies strongly show that frequent intake of these beverages contributes to the onset of the metabolic syndrome, diabetes and hypertension."

The authors reviewed 36 studies on the cardiometabolic effects of sugar-sweetened beverage consumption from the past decade. Since some recent studies reached conflicting findings regarding the relationship between beverage consumption and health conditions such as diabetes and heart diseases, the researchers critically assessed the research landscape for overall trends.

Although there were some studies with negative or neutral findings, most of the studies supported a link between sugar-sweetened beverage consumption and the risk of developing the metabolic syndrome. Most of the analyzed studies looked at individuals who drank more than five sugar-sweetened beverages a week.

Studies on diet and diabetes revealed consuming as few as two servings of sugar-sweetened beverages a week was linked to an increased risk of developing type 2 diabetes. Several of the analyzed studies found drinking at least one sugar-sweetened beverage a day was associated with elevated blood pressure.

"The findings demonstrate there is a clear need for public education about the harmful effects of excess consumption of sugar-sweetened beverages," Essop said. "But our understanding of this topic would benefit from additional research to further clarify how sugar-sweetened beverages affect our health. We do see some limitations in the current research on this topic, including a need for longer-term studies and standardized research methods."
-end-
Other authors of the review are Gaurang Deshpande and Rudo F. Mapanga of Stellenbosch University.

The work was supported by South Africa's National Research Foundation and Stellenbosch University.

The review, "Frequent Sugar-sweetened Beverage Consumption and the Onset of Cardiometabolic Diseases: Cause for Concern?," will be published online at https://academic.oup.com/jes/article-lookup/doi/10.1210/js.2017-00262.

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world's oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at http://www.endocrine.org. Follow us on Twitter at @TheEndoSociety and @EndoMedia.

The Endocrine Society

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.